newspaper "Kommersant": company MDS will stop deliveries to Russian Federation the preparation "Zepatir"

This unique in own way means against the hepatitis C, patented till 2030. It designate one of the most demanded at patients with this diagnosis to Russian Federation, annually the state buys medicine on 1 billion rubles. Experts calm: "Zepatir's" leaving does not become critical. As a last resort domestic producers will be given the license of the American firm forcibly...